These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7265167)

  • 1. Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus.
    de Azavedo J; Arbuthnott JP
    J Med Microbiol; 1981 Aug; 14(3):341-4. PubMed ID: 7265167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1991 Oct; 14(4):357-62. PubMed ID: 1775093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus.
    Murono K; Fujita K; Yoshioka H
    Pediatr Infect Dis J; 1988 May; 7(5):313-5. PubMed ID: 3380582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of clinical S. aureus-isolates for the production of exfoliative toxin. A methodological study.
    Elsner P; Hartmann AA; Lenz W; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):216-20. PubMed ID: 3936308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic aspects of Staphylococcus aureus and MRSA--typing and extracellular toxins and proteins].
    Kurosaka K
    Nihon Rinsho; 1992 May; 50(5):932-7. PubMed ID: 1507447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmids in epidermolytic strains of Staphylococcus aureus.
    O'Reilly M; Dougan G; Foster TJ; Arbuthnott JP
    J Gen Microbiol; 1981 May; 124(1):99-107. PubMed ID: 6275008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis.
    Kaplan MH; Chmel H; Hsieh HC; Stephens A; Brinsko V
    J Clin Microbiol; 1986 Jan; 23(1):83-91. PubMed ID: 3700612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome.
    Kondo I; Sakurai S; Sarai Y; Futaki S
    J Clin Microbiol; 1975 May; 1(5):397-400. PubMed ID: 126250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration by electrosyneresis of 2 exfoliation serotypes produced by Staphylococcus aureus].
    Piémont Y; Monteil H
    Ann Microbiol (Paris); 1983; 134A(2):169-75. PubMed ID: 6870085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-labile toxin-producing isolates of Pasteurella multocida from rabbits.
    Suckow MA; Chrisp CE; Foged NT
    Lab Anim Sci; 1991 Apr; 41(2):151-6. PubMed ID: 1658444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients.
    Piemont Y; Rasoamananjara D; Fouace JM; Bruce T
    J Clin Microbiol; 1984 Mar; 19(3):417-20. PubMed ID: 6232283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxin-producing pasteurellas in a cattle herd].
    Ehlers J; Schimmel D; Sachse K; Boehnke HJ; Schöss P
    Dtsch Tierarztl Wochenschr; 1993 Dec; 100(12):488-91. PubMed ID: 8306868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and serological differentiation of staphylococcal exfoliative toxin synthesized under chromosomal and plasmid control.
    Wiley BB; Rogolsky M
    Infect Immun; 1977 Nov; 18(2):487-94. PubMed ID: 411758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus hyicus exfoliative toxin: purification and demonstration of antigenic diversity among toxins from virulent strains.
    Andresen LO; Bille-Hansen V; Wegener HC
    Microb Pathog; 1997 Feb; 22(2):113-22. PubMed ID: 9050000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus haemolysins: their use in strain typing.
    Eliás B; Köfer J
    Acta Microbiol Acad Sci Hung; 1980; 27(3):183-90. PubMed ID: 7446213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus of phage type 187 isolated from people occurred to be a genes carrier of eneterotoxin C and toxic shock syndrome toxin-1 (TSST-1).
    Piechowicz L; Garbacz K; Galiński J
    Int J Hyg Environ Health; 2008 Jul; 211(3-4):273-82. PubMed ID: 17997135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-mediated transformation in mutants of phage group 2 Staphylococcus aureus.
    Martin SM; Rogolsky M
    Can J Microbiol; 1980 Aug; 26(8):938-51. PubMed ID: 6450630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.